- Home
- CLX vs MDGL Comparison
CLX vs MDGL Comparison
Compare CLX & MDGL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | CLX | MDGL |
|---|---|---|
| Founded | 1913 | 2011 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Specialty Chemicals | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 13.0B | 11.5B |
| IPO Year | 1994 | 2005 |
Fundamental Metrics
Financial Performance| Metric | CLX | MDGL |
|---|---|---|
| Price | $109.29 | $425.29 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 18 | 19 |
| Target Price | $97.00 | ★ $688.78 |
| AVG Volume (30 Days) | ★ 3.4M | 526.8K |
| Earning Date | 11-02-2026 | 11-03-2026 |
| Dividend Yield | ★ 4.62% | N/A |
| EPS Growth | ★ 189.78 | N/A |
| EPS | ★ 1.39 | N/A |
| Revenue | ★ $6,124,000,000.00 | $180,133,000.00 |
| Revenue This Year | $13.66 | $65.40 |
| Revenue Next Year | $2.23 | $37.87 |
| P/E Ratio | $77.55 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $79.12 | $353.54 |
| 52 Week High | $128.90 | $615.00 |
Technical Indicators
Market Signals| Indicator | CLX | MDGL |
|---|---|---|
| Relative Strength Index (RSI) | 82.40 | 40.94 |
| Support Level | $91.99 | $416.21 |
| Resistance Level | $128.90 | $553.95 |
| Average True Range (ATR) | 3.84 | 24.52 |
| MACD | 1.93 | 3.61 |
| Stochastic Oscillator | 96.25 | 54.17 |
Price Performance
Historical ComparisonAbout CLX Clorox Company (The)
Since its inception more than 100 years ago, Clorox has expanded to operate in an array of consumer product categories, including cleaning supplies, laundry care, trash bags, cat litter, charcoal, food dressings, water filtration products, and natural personal-care products. Beyond its namesake brand, the firm's portfolio includes Liquid-Plumr, Pine-Sol, S.O.S, Tilex, Kingsford, Fresh Step, Glad, Hidden Valley, KC Masterpiece, Brita, and Burt's Bees. Nearly 85% of Clorox's sales come from its home turf.
About MDGL Madrigal Pharmaceuticals Inc.
Madrigal Pharmaceuticals Inc is a biopharmaceutical company focused on delivering novel therapeutics for metabolic dysfunction-associated steatohepatitis (MASH), a serious liver disease with high unmet medical need that can lead to cirrhosis, liver failure, liver cancer, need for liver transplantation and premature mortality. Its medication, Rezdiffra (resmetirom), is a once-daily, oral, liver-directed thyroid hormone receptor beta agonist designed to target key underlying causes of MASH.